共 76 条
- [11] Summers K.K., Hardin T.C., Gore S.J., Graybill J.R., Therapeutic drug monitoring of systemic antifungal therapy, Journal of Antimicrobial Chemotherapy, 40, 6, pp. 753-764, (1997)
- [12] Bruggemann R.J., Touw D.J., Aarnoutse R.E., Et al., International interlaboratory proficiency testing program for measurement of azole antifungal plasma concentrations, Antimicrob Agents Chemother, 53, pp. 303-305, (2009)
- [13] Trifilio S.M., Bennett C.L., Yarnold P.R., McKoy J.M., Parada J., Mehta J., Chamilos G., Palella F., Kennedy L., Mullane K., Tallman M.S., Evens A., Scheetz M.H., Blum W., Kontoyiannis D.P., Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy, Bone Marrow Transplantation, 39, 7, pp. 425-429, (2007)
- [14] Trifilio S., Singhal S., Williams S., Et al., Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole, Bone Marrow Transplant, 40, pp. 451-456, (2007)
- [15] Hope W.W., Billaud E.M., Lestner J., Denning D.W., Therapeutic drug monitoring for triazoles, Curr Opin Infect Dis, 21, pp. 580-586, (2008)
- [16] Trifilio S.M., Yarnold P.R., Scheetz M.H., Et al., Serial plasma voriconazole concentrations after allogeneic hematopoietic stem cell transplantation, Antimicrob Agents Chemother, 53, pp. 1793-1796, (2009)
- [17] Bennett J.E., Dismukes W.E., Duma R.J., A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis, New England Journal of Medicine, 301, 3, pp. 126-131, (1979)
- [18] Van D.H.C.M., Saag M.S., Cloud G.A., Hamill R.J., Graybill J.R., Sobel J.D., Johnson P.C., Tuazon C.U., Kerkering T., Moskovitz B.L., Powderly W.G., Dismukes W.E., Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome, New England Journal of Medicine, 337, 1, pp. 15-21, (1997)
- [19] Andes D., Van Ogtrop M., In vivo characterization of the pharmacodynamics of flucytosine in a neutropenic murine disseminated candidiasis model, Antimicrob Agents Chemother, 44, pp. 938-942, (2000)
- [20] Groll A.H., Piscitelli S.C., Walsh T.J., Clinical pharmacology of systemic antifungal agents: A comprehensive review of agents in clinical use, current investigational compounds, and putative targets for antifungal drug development, Adv Pharmacol, 44, pp. 343-500, (1998)